Le Lézard
Classified in: Health

InfuTronix to Launch Nimbustm II EMS At The 2017 EMS World Expo


RICHARDSON, Texas, Oct. 16, 2017 /PRNewswire-iReach/ -- Infutronix, a global medical device manufacturer based in Massachusetts, is proud to announce the launch of a new electronic ambulatory infusion pump for the EMS market, the Nimbustm II EMS pump, to be debuted at the 2017 EMS World Expo in Las Vegas, October 16-20. 

Built on the proven Nimbustm ambulatory infusion pump platform, the Nimbus II EMS is a small, lightweight, smart, and durable infusion pump, making it a perfect candidate for emergency transport use. This pump is highly customizable with editable presets, protocol and global safeguards, and names. Included are industry standard operating modes such as weight-based programming and continuous volume over time. Choose from several accessories made specifically for the EMS market including disposable skins for easy de-contamination, durable pole mounts, and carry pouches. The Nimbus II EMS is priced to be extremely affordable and leased for optimal performance.

Come visit us at EMS World Expo 2017 at booth 1754!

Visit our website to learn more at www.nimbusEMS.com.

About InfuTronix, LLC

Infutronix is a leading infusion pump company aiming to increase patient safety and streamline clinical workflow. It provides a portfolio of ambulatory infusion pump products designed to increase customer satisfaction and enhance patient safety in a cost-effective solution. InfuTronix's market focus is acute care pain management where there is a need for easy-to-use high-end electronic infusion pumps that have a high level of accuracy and flexibility for the unique needs of the ambulatory pump user.  The mission of InfuTronix is to design forward-thinking devices that are capable of setting standards in the evolving pain management programs while understanding the current market needs. Infutronix is headquartered in Natick, Massachusetts.  For more information, please visit www.nimbuspump.com.

Media Contact: Monica Richamond, Submit Press Release 123, 855-ONE-SUBMIT (855-663-7826), [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE InfuTronix, LLC


These press releases may also interest you

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...



News published on and distributed by: